The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index; 10 of the 12 sources its claims cite were checked for support.
Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study
Open accessAbstract
Background: Around 40-60% of major depressive disorder (MDD) patients treated with either SSRIs or SNRIs have experienced emotional blunting. It is cited as a prevailing cause for discontinuation of antidepressant medications in patients with MDD. Aim: To determine the prevalence of emotional blunting with antidepressants in patients of MDD visiting psychiatric OPD in Kashmir. Materials and Methods: This was cross-sectional study conducted over a period of 18 months. A total of 369 patients were diagnosed as MDD as per DSM-5. A Hamilton Depression Rating Scale score of ≤7 and those on a single class of antidepressant for at least 2 months were taken up for the study. They were screened for emotional blunting, and those who responded in affirmative as mildly, moderately, or severely were further evaluated by asking them to finish the Oxford Depression Questionnaire. Results: The prevalence of emotional blunting in our study was reported to be 46.07%. The mean age of the participants was 40.9 ± 10.6 years with the majority being females (71%), married (69.38%), and from nuclear families (75.88%). Emotional blunting was most commonly associated with duloxetine (73.68%) and least with bupropion (31.82%). Nearly 40% of the patients had considered stopping their antidepressant due to emotional numbing. Conclusion: Recognizing and addressing emotional blunting is crucial in optimizing therapeutic outcomes and ensuring patient-centered care in depressive management. Given a significant number of depressive patients taking antidepressants may experience emotional blunting and subsequent discontinuation of the same. Routine assessment and timely management are essential for optimized clinical outcomes in patients with depression.
Overview
CoChat Summary
TL;DR
In this hospital-based cross-sectional study of 369 MDD patients in remission on antidepressant monotherapy in Kashmir, 46.07% experienced emotional blunting. Duloxetine was most commonly associated with emotional blunting (73.68%) and bupropion least (31.82%), with nearly 40% considering stopping their antidepressant due to emotional numbing.
Key findings
- Of 369 patients, 170 (46.07%) experienced emotional blunting and 199 (53.93%) did not.
- Mean age was 40.9 ± 10.6 years; the majority were female (71%), married (69.38%), and from nuclear families (75.88%).
- Emotional blunting was most commonly associated with duloxetine (73.68%) and least with bupropion (31.82%); nearly 40% of patients had considered stopping their antidepressant due to emotional numbing.
- Patients with emotional blunting had higher HDRS scores than those without; the study found a significant difference in ODQ scores and that emotional blunting was directly correlated with antidepressant dose, duration of illness, and total time on antidepressant monotherapy.
Methods
- Hospital-based, noninterventional, cross-sectional study conducted at a tertiary care hospital over 18 months (November 2022 to April 2024).
- Included 369 patients diagnosed with MDD per DSM-5, in remission (HDRS ≤7), aged 18 years and above, on a single class of antidepressant for at least 2 months, who provided written informed consent; excluded comorbid psychiatric disorders and other psychotropic medications.
- Emotional blunting was screened with a validated question; those responding affirmatively as mild, moderate, or severe completed the Oxford Depression Questionnaire. Data were collected via structured clinical interview and treatment records, analyzed using SPSS version 23.0 with descriptive statistics, chi-square tests, and P < 0.05 considered significant.
Limitations
- The paper states: no control group; sample size not calculated; cross-sectional design restricts causality; uncontrolled, nonblinded, time-limited, small sample size; possible selection and recall biases; and findings from a tertiary psychiatric facility may not generalize to community or primary care settings.
- No additional limitations are evident beyond those stated in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 2 Not valid · 3 Not checked · 23 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A study showed that 45% of patients believed their antidepressant negatively influenced their emotions, and nearly 39% considered discontinuation.[9]”
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > Abstract > Conclusion:
What the sources say
- Partly supportedcites [9] Christensen MC Ren H Fagiolini A Emotional blunting in patients with depression. Part IV: Differences between patient and physician perceptions Ann Gen Psychiatry 2022 21 22 35733157 PMC9215037 sourceExperimental — accuracy not yet measured
The Results (ODQ and FAST questionnaire findings) support the 45% figure. They report that 39% were either considering stopping or had already stopped their antidepressant because of perceived emotion-related side effects; they do not give 39% as the proportion considering discontinuation alone. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our findings correspond to those of Christensen et al.,[9] who reported emotional restriction in 45% of antidepressant users.”
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > DISCUSSION
What the sources say
- Partly supportedcites [9] Christensen MC Ren H Fagiolini A Emotional blunting in patients with depression. Part IV: Differences between patient and physician perceptions Ann Gen Psychiatry 2022 21 22 35733157 PMC9215037 sourceExperimental — accuracy not yet measured
The Results (ODQ and FAST questionnaire findings) report that 45% of surveyed patients believed their antidepressant was negatively affecting their emotions. But the Methods (Abstract) say respondents already reported emotional blunting and were taking prescribed antidepressants, so 45% is not the prevalence of emotional restriction among antidepressant users generally. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A study showed that 45% of patients believed their antidepressant negatively influenced their emotions, and nearly 39% considered discontinuation.[9]”
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > Abstract > Conclusion:
What the sources say
- Supportedcites [9] Christensen MC Ren H Fagiolini A Emotional blunting in patients with depression. Part IV: Differences between patient and physician perceptions Ann Gen Psychiatry 2022 21 22 35733157 PMC9215037 source
The Results (ODQ and FAST questionnaire findings) report that 45% of patients believed their antidepressant negatively affected their emotions. They also report that 39% were considering stopping or had already stopped their antidepressant because of perceived emotion-related side effects; the citing sentence compresses this to 'considered discontinuation.' (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Studies show a correlation between emotional blunting and higher depression severity scores.”
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > Abstract > Conclusion:
What the sources say
- Could not verifycites [5] McCabe C Mishor Z Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers Neuroimage 2011 57 1317 23 21640839 PMC3141109 sourceExperimental — accuracy not yet measured
The Methods (Participants; page unavailable) list a depression inventory and pleasure scales, but the Results (Demographic details and mood ratings; page unavailable) report group comparisons, not a correlation between emotional blunting and depression severity. Searches for emotional blunting, depressive-symptom severity, and their association found no passage making the claimed link. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Despite their efficacy, antidepressants, especially SSRIs and SNRIs, are associated with emotional blunting in approximately 40–60% of patients.”
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > Abstract > Conclusion:
What the sources say
- Partly supportedcites [8] Fagiolini A Florea I Loft H Christensen MC Effectiveness of vortioxetine on emotional blunting in patients with major depressive disorder with inadequate response to SSRI/SNRI treatment J Affect Disord 2021 283 472 9 33516560 sourceExperimental — accuracy not yet measured
The Introduction reports that about 50–60% of patients with major depressive disorder treated with SSRIs or SNRIs report some emotional blunting, which may be related to medication. This supports the association, but not the claim’s 40% lower bound or its unqualified reference to patients. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
17 more claims · 3 with their cited sources checked
Create a free account to see all 36 claims and to verify the 2 references still open.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 5
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > DISCUSSION
“Our study found a significant difference in the ODQ scores of MDD patients with and without emotional blunting.”
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > MATERIALS AND METHOD > Study area and design
“Patients who responded affirmatively (mild, moderate, or severe) were further assessed using the Oxford Depression Questionnaire (ODQ), while those reporting no such experience were not administered the ODQ.”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > Abstract > Results:
“Emotional blunting was most commonly associated with duloxetine (73.68%) and least with bupropion (31.82%).”
§ Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study > DISCUSSION
“The phenomenon being a side effect of antidepressants is supported by lower rates of blunting with bupropion and duloxetine, compared to other drugs prescribed to our study participants.”
Citations
Cites
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
A systematic review and meta-regression of the prevalence and incidence of perinatal depression
Woody, C. A., Ferrari, A. J., Siskind, D. J., Whiteford, H. A., & Harris, M. G. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.003 · Cited by 1,577
Pedersen, C. B., Mors, O., Bertelsen, A., Waltoft, B. L., Agerbo, E., McGrath, J. J., Mortensen, P. B., & Eaton, W. W. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.16 · Cited by 619
Prevalence and determinants of depression among old age: a systematic review and meta-analysis
Zenebe, Y., Akele, B., W/Selassie, M., & Necho, M. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-021-00375-x · Cited by 607
McCabe, C., Mishor, Z., Cowen, P. J., & Harmer, C. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.001 · Cited by 365
Emotional blunting with antidepressant treatments: A survey among depressed patients
Goodwin, G. M., Price, J., De Bodinat, C., & Laredo, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.048 · Cited by 202
McCabe, C., & Mishor, Z. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.051 · Cited by 184
Fagiolini, A., Florea, I., Loft, H., & Christensen, M. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.106 · Cited by 127
Prevalence of anxiety, depression and post-traumatic stress disorder in the Kashmir Valley
Housen, T., Lenglet, A., Ariti, C. A., Shah, S., Shah, H., Ara, S., Viney, K. A., Janes, S., & Pintaldi, G. (2017) · BMJ Global Health · doi:10.1136/bmjgh-2017-000419 · Cited by 122
Rosenblat, J. D., Simon, G. E., Sachs, G. S., Deetz, I., Doederlein, A., DePeralta, D., Dean, M. M., & McIntyre, R. S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.027 · Cited by 92
Research works printed but not linked: 2
- Dar, 2016, Socio-demographic and clinical profile of patients suffering from severe depressive disorders in Kashmir valley, Int J Contemp Med Res, 3, 3389
- Ahmed, 2023, A cross sectional study to assess the role of socio-economic factors in causing depression among the rural population, J Community Health Manage, 6, 113
Cited by
Fialho, I., & Novais, F. (2026) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-026-00390-3
D-cycloserine-augmented SAINT for treatment-resistant depression: A case series
Weber, E. M. M., Nejad, R., Tran, I., Kratter, I. H., Ahmed, M., & Bentzley, B. S. (2026) · Transcranial magnetic stimulation . · doi:10.1016/j.transm.2026.100334
Metadata
- Authors
- Nazir, N., Nazir, D., Mehmood, R., Wani, Z. A., & Raj, R.
- Affiliations
- Government Medical College (IN)
- Corresponding author
- Raj, Rajnish
- Venue
- Industrial Psychiatry Journal
- Published
- 2026-01
- Volume
- 35
- Issue
- 1
- Pages
- 54-59
- ISSN
- 0972-6748 (ISSN-L)
- 0976-2795
- PMC
- PMC12923221
- OpenAlex
- W7124862549
- Cited by
- 2
- References
- 22
- Citations by year
- 2026: 2
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Industrial Psychiatry Journal (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- emotional blunting, major depressive disorder, antidepressants, duloxetine, bupropion, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, antidepressant discontinuation, prevalence, Kashmir
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study. https://app.cochat.ai/papers/10.4103/ipj.ipj_201_25
- The paper
- Nazir, N., Nazir, D., Mehmood, R., Wani, Z. A., & Raj, R. (2026). Emotional blunting with antidepressants in major depressive disorder patients: A hospital-based cross-sectional study. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_201_25
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.